| State: | California |
|---|---|
| Address: | 9640 Towne Centre Dr Suite 200, San Diego, CA 92121 |
| Zip code: | 92121 |
| Phone: | (858) 587-5870 |
| Website: | https://www.breastcancerindex.com/ |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Breast Cancer Index, use the form below and your opinion, advice or comment will appear in this space.
The phone number for Breast Cancer Index is (858) 587-5870.
Breast Cancer Index is located at 9640 Towne Centre Dr Suite 200, San Diego, CA 92121
The website (URL) for Breast Cancer Index is: https://www.breastcancerindex.com/
Breast Cancer Index is the only validated tool to help with patient selection for extended endocrine therapy in ER+ early stage breast cancer. The Prognostic and Predictive Power of Breast Cancer Index. 2017 Miami Breast Cancer Conference (MBCC) Presentation.
Breast Cancer Index (BCI) combines two independent biomarkers, HOXB13:IL17BR (H:I) and the 5-gene molecular grade index (MGI), that assess estrogen-mediated signalling and tumor grade, respectively. BCI stratifies early-stage estrogen-receptor positive (ER+), lymph-node negative (LN...
The Breast Cancer Index test, made by bioTheranostics, analyzes the activity of seven genes to help predict the risk of node-negative, hormone-receptor-positive breast cancer coming back 5 to 10 years after diagnosis. The test can help women and their doctors decide if extending hormonal therapy 5...
Breast Cancer Index demonstrates sustainable prognostic power and particularly addresses the unmet medical need of bioTheranostics discovers, develops and commercializes molecular diagnostic tests for cancer patients. For more information, call 1-858-587-5870 or visit www.bioTheranostics.com.
SAN DIEGO--(BUSINESS WIRE)--Biotheranostics, Inc. announces recommendations for Breast Cancer Index in both the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Breast Cancer and the American Society of Clinical Oncology (ASCO)...
The study was designed to evaluate Breast Cancer Index (BCI), a continuous risk index to predict recurrence and survival of ER (+) and node "The positive outcomes presented this week from the latest CancerTYPE ID and Breast Cancer Index clinical studies are very exciting and reinforce the...
Отказаться от подписки на канал "Breast Cancer Index"? To Extend or End Endocrine Therapy After Year 5 for ER+ Breast Cancer Patients?
Patients in Breast Cancer Index (BCI) risk groups (% in risk category). ME, Schnabel CA, Goss PE, Cuzick J, Dowsett M (2012) Evaluation of prognostic and predictive performance of Breast Cancer Index and its components in hormonal receptor-positive breast cancer patients: a TransATAC study.
Breast cancer and benign conditions of the breasts, Here is our amazing breast cancer index, sprinkled with commentary by Dr. Halls and the Moose. My older breast cancer website pages are still here. There's actually hundreds of pages of information and some of it is really good and pretty...
Breast Cancer Index (BCI) Lansdale: HAYES, Inc.. Genetic Testing Publication. 2014. Authors' conclusions. Breast cancer is the most common cancer affecting women, with > 200,000 newly identified cases every year in the United States.